Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Chiron halts clinical development of rhIGF-I in osteoarthritis

July 25, 2000

Major European market launches for Enbrel

July 21, 2000

Takeda patents thiazolidine MMP inhibitors

July 19, 2000

Ciblex's CBX-21404 shows biological activity in mice

July 18, 2000

Methods of treating or preventing arthritic conditions with MEK inhibitors

July 14, 2000

Integrin-inhibitory compounds designed by Celltech for inflammatory and immune conditions

July 14, 2000

Nonsteroidal antiinflammatory agents with reduced metabolic effects presented by Schering

July 14, 2000

Serono licenses TNF antibody patents to Knoll and Centocor

July 14, 2000

Centaur's new antiinflammatory agents reportedly act by inhibiting COX-2 induction

July 13, 2000

Arthritis Advisory Committee recommends new approval for Remicade

July 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.